| Filed On | Filing |
|---|---|
| 10 Nov 2026 | SCHEDULE 13G |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
MannKind Reports Third Quarter 2026 Financial Results and Provides Business Update |
| 28 Sep 2026 |
Form 4: Binder Steven B., Director
Sold 39,051 shares ($128K) |
| 25 Sep 2026 | 144 |
| 14 Sep 2026 |
Form 4: Binder Steven B., Director
Sold 33,558 shares ($128K) |
| 10 Sep 2026 | 144 |
| 21 Aug 2026 |
8-K: Other Events
We have acted as counsel to MannKind Corporation, a Delaware corporation (the “Company”), in connection with the registration for resale by the selling stockholders named in the Prospectus (defined below) of up to 12,853,470 shares of th... |
| 21 Aug 2026 | 424B7 |
| 14 Aug 2026 | SCHEDULE 13G |
| 10 Aug 2026 |
Form 4: Binder Steven B., Director
Sold 39,051 shares ($159K) |
| 07 Aug 2026 | 144 |
| 05 Aug 2026 | 10-Q |
| 05 Aug 2026 |
8-K: Results of Operations and Financial Condition
MannKind Reports Second Quarter 2026 Financial Results and Provides Business Update |
| 31 Jul 2026 | SCHEDULE 13G |
| 24 Jul 2026 |
8-K: Unregistered Sales of Equity Securities; Other Events
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of July 23, 2026, is entered into by and among MannKind Corporation, a Delaware corporation (the “Company”), and the several investors signatory hereto (individually, as an ... |
| 17 Jul 2026 |
Form 4: Prentiss Christopher B, Chief Financial Officer
Gave up 22,247 shares to cover exercise price or tax ($91K) |
| 17 Jul 2026 |
Form 4: Marasco Dominic, Pres, Endocrine Business Unit
Gave up 3,623 shares to cover exercise price or tax ($14.8K) |
| 17 Jul 2026 |
Form 4: Tross Stuart A, Chief People & Workpl Officer
Received 93,790 shares by exercise or conversion · Gave up 65,808 shares to cover exercise price or tax ($269K) |
| 17 Jul 2026 |
Form 4: Castagna Michael, Director
Received 350,260 shares by exercise or conversion · Gave up 363,200 shares to cover exercise price or tax ($1.49M) |
Loading...